AUB
OVID icon

Atlantic Union Bankshares’s Ovid Therapeutics OVID Stock Holding History

Atlantic Union Bankshares’s Portfolio OVID Stock Details OVID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.11K Hold
2,300
– – ﹤0.01% 1422
2025
Q4 		$3.75K Hold
2,300
– – ﹤0.01% 1430
2025
Q3 		$2.99K Hold
2,300
– – ﹤0.01% 1440
2025
Q2 		$759 Buy
+2,300
New +$693 ﹤0.01% 1140

Other funds holding OVID

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Atlantic Union Bankshares's OVID Position: Q1 2026 in Review

Atlantic Union Bankshares held its Ovid Therapeutics (OVID) position steady in Q1 2026 at 2,300 shares worth $5.11K. The position accounts for ﹤0.01% of the portfolio, ranked #1422.

Atlantic Union Bankshares first reported a position in OVID in Q2 2025 and has held it in 4 quarters since. 103 funds tracked by Wall St. Rank hold OVID as of Q1 2026.

  • Atlantic Union Bankshares held 2,300 shares of Ovid Therapeutics worth $5.11K as of Q1 2026.
  • Atlantic Union Bankshares left its Ovid Therapeutics share count unchanged in Q1 2026.
  • Ovid Therapeutics made up ﹤0.01% of Atlantic Union Bankshares's portfolio in Q1 2026, its #1422 holding.
  • Atlantic Union Bankshares first reported a position in Ovid Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • 103 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q1 2026.

Based on Atlantic Union Bankshares's 13F filing for Q1 2026, filed 12 May 2026.